AXSM EPS Estimates
Axsome Therapeutics, Inc.
$170.08
-$2.89(-1.67%)
49
Overall
40
Value
36
Tech
71
Quality
Market Cap
$9.06B
Volume
1.07M
52W Range
$117.30 - $260.19
Target Price
$279.64
AXSM EPS estimates: the consensus estimate for Axsome Therapeutics, Inc.'s current fiscal year is -$2.92 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
AXSM EPS Estimates
- EPS estimate, current quarter
- $-0.56
- EPS estimate, next quarter
- $-0.07
- EPS estimate, current year
- $-2.92
- EPS estimate, next year
- $3.78
- EPS growth, 3-year
- +7.17%
| Fiscal year | EPS |
|---|---|
| 2025 | $-3.68 |
| 2024 | $-5.99 |
| 2023 | $-5.27 |
| 2022 | $-4.60 |
| 2021 | $-3.47 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AXSM | $170.08 | -1.7% | 1.07M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Axsome Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW